ARMISTICE CAPITAL LLC 13D and 13G filings for Vivos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:49 pm Purchase | 2024-09-30 | 13G | Vivos Therapeutics, Inc. VVOS | ARMISTICE CAPITAL LLC | 250,277 4.990% | 75,178 (+42.93%) | Filing |
| 2024-02-14 3:57 pm Purchase | 2023-12-31 | 13G | Vivos Therapeutics, Inc. VVOS | ARMISTICE CAPITAL LLC | 175,099 9.990% | 175,099 (New Position) | Filing |